↓ Skip to main content

Dove Medical Press

Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device

Overview of attention for article published in Patient preference and adherence, July 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
24 Mendeley
Title
Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device
Published in
Patient preference and adherence, July 2013
DOI 10.2147/ppa.s46990
Pubmed ID
Authors

Ad A Kaptein

Abstract

Administering growth-hormone therapy (GHT) is a long-term treatment, associated with avoidance and phobic behaviors in the children involved. The current study examined GHT users' perceptions of a new needle-free device (ZomaJet Vision X [10 mg/mL]) with a lower injection volume compared to the traditional device.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 25%
Researcher 3 13%
Student > Doctoral Student 2 8%
Student > Bachelor 2 8%
Student > Master 2 8%
Other 2 8%
Unknown 7 29%
Readers by discipline Count As %
Medicine and Dentistry 9 38%
Psychology 3 13%
Nursing and Health Professions 2 8%
Social Sciences 1 4%
Engineering 1 4%
Other 0 0%
Unknown 8 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2013.
All research outputs
#19,944,091
of 25,373,627 outputs
Outputs from Patient preference and adherence
#1,293
of 1,757 outputs
Outputs of similar age
#150,688
of 206,705 outputs
Outputs of similar age from Patient preference and adherence
#32
of 38 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,705 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.